Search - tctmd.com

Displaying 1 - 15 of 15

Sort: Relevancy | Date

News Conference News AHA 2020

Both Statins and Placebos Produce ‘Very Real’ Side Effects: SAMSON

Michael O'Riordan

November 15, 2020

Presentation TCT 2017

Established TMVR 1: Cardiaq - Device Description, Strengths and Weaknesses, and Updated Summary Outcomes

Presenter: Howard C. Herrmann, Michael J. Mack, James B. Hermiller Jr.

October 31, 2017

News Daily News

¿Relaja el Acuerdo de la FDA con Amarin el Control de las Promociones Fuera de Indicación?

Michael O'Riordan

March 09, 2016

News Daily News

Will FDA’s Settlement With Amarin Weaken Agency Oversight of Off-Label Promotion?

Michael O'Riordan

March 09, 2016

News Daily News

FDA 与阿玛琳之间的和解是否会减弱该局对标签外用途推广的监督？

Michael O'Riordan

March 09, 2016

News Daily News

肾脏去神经支配试验在很大程度上会受到意外偏倚的影响

Todd Neale

January 19, 2016

News Daily News

Renal Denervation Trials Have Largely Fallen Victim to Unintentional Bias

Todd Neale

January 19, 2016

News Daily News

Los Ensayos de Denervación Renal Han Sido Víctimas de Sesgos Involuntarios

Todd Neale

January 19, 2016

Presentation

Quantifying the 3 Biases That Lead to Unintentional Overestimation of the Effect of Renal Denervation

Presenter: James P. Howard

January 11, 2016

Presentation TCT 2015

TAVR 2015: Current Status

Presenter: Blase A. Carabello, Howard C. Herrmann, James B. Hermiller Jr

October 12, 2015

News Industry News

Vascular Solutions Expands Launch of PolarCath(TM) System With 0.035” Catheters

August 03, 2015

News Features TCT 2014

Thoughtful Insights at TCT: Many Questions Remain Around Treatment of Valvular Disease

Todd Neale

October 24, 2014

Presentation TCT 2014

Hemodynamics of Dynamic Obstruction

Presenter: John S. Douglas Jr, Sherif F. Nagueh, Howard C. Herrmann, James B. Hermiller Jr

September 16, 2014

Presentation TCT 2012

No Difference In Long-term Major Adverse Cardiac Event Rates Between Paclitaxel-eluting and Sirolimus-eluting Stents.

Presenter: James P. Howard, Zia Buckhoree, Dan A. Jones, Sean M. Gallagher, Krishnaraj S. Rathod, Ajay K. Jain, Charles Knight, Anthony Mathur, Andrew Wragg

January 03, 2012

BIO

Advertisement

Both Statins and Placebos Produce ‘Very Real’ Side Effects: SAMSON

Established TMVR 1: Cardiaq - Device Description, Strengths and Weaknesses, and Updated Summary Outcomes

¿Relaja el Acuerdo de la FDA con Amarin el Control de las Promociones Fuera de Indicación?

Will FDA’s Settlement With Amarin Weaken Agency Oversight of Off-Label Promotion?

FDA 与阿玛琳之间的和解是否会减弱该局对标签外用途推广的监督？

肾脏去神经支配试验在很大程度上会受到意外偏倚的影响

Renal Denervation Trials Have Largely Fallen Victim to Unintentional Bias

Los Ensayos de Denervación Renal Han Sido Víctimas de Sesgos Involuntarios

Quantifying the 3 Biases That Lead to Unintentional Overestimation of the Effect of Renal Denervation

TAVR 2015: Current Status

Vascular Solutions Expands Launch of PolarCath(TM) System With 0.035” Catheters

Thoughtful Insights at TCT: Many Questions Remain Around Treatment of Valvular Disease

Hemodynamics of Dynamic Obstruction

No Difference In Long-term Major Adverse Cardiac Event Rates Between Paclitaxel-eluting and Sirolimus-eluting Stents.

Keith C. Ferdinand

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content